カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアザシチジン医薬品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Azacitidine Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19166）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19166
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアザシチジン医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アザシチジン医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアザシチジン医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アザシチジン医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・Vidaza®、ジェネリック Vidaza®

用途別セグメントは次のように区分されます。
・不応性貧血（RA）、芽球過剰不応性貧血（RAEB）、慢性骨髄単球性白血病（CMMoL）、その他

世界のアザシチジン医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Celgene、Mylan、Shilpa Medicare、Accord Healthcare、Natco Pharma、Dr. Reddy's Laboratories

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アザシチジン医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアザシチジン医薬品メーカーの企業概要、2019年～2022年までのアザシチジン医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアザシチジン医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アザシチジン医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアザシチジン医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアザシチジン医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアザシチジン医薬品の産業チェーンを掲載しています。
・第13、14、15章では、アザシチジン医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アザシチジン医薬品の概要
- 種類別分析（2017年vs2021年vs2028年）：Vidaza®、ジェネリック Vidaza®
- 用途別分析（2017年vs2021年vs2028年）：不応性貧血（RA）、芽球過剰不応性貧血（RAEB）、慢性骨髄単球性白血病（CMMoL）、その他
- 世界のアザシチジン医薬品市場規模・予測
- 世界のアザシチジン医薬品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Celgene、Mylan、Shilpa Medicare、Accord Healthcare、Natco Pharma、Dr. Reddy's Laboratories
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：Vidaza®、ジェネリック Vidaza®
・用途別分析2017年-2028年：不応性貧血（RA）、芽球過剰不応性貧血（RAEB）、慢性骨髄単球性白血病（CMMoL）、その他
・アザシチジン医薬品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アザシチジン医薬品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アザシチジン医薬品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アザシチジン医薬品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アザシチジン医薬品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Azacitidine Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Azacitidine Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Refractory anemia (RA) accounting for % of the Azacitidine Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Vidaza® segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Azacitidine Drug include Celgene, Mylan, Shilpa Medicare, Accord Healthcare, and Natco Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Azacitidine Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vidaza®
Generic Vidaza®
Market segment by Application can be divided into
Refractory anemia (RA)
Refractory anemia with excess blasts (RAEB)
Chronic myelomonocytic leukemia (CMMoL)
Others
The key market players for global Azacitidine Drug market are listed below:
Celgene
Mylan
Shilpa Medicare
Accord Healthcare
Natco Pharma
Dr. Reddy’s Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Azacitidine Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Azacitidine Drug, with price, sales, revenue and global market share of Azacitidine Drug from 2019 to 2022.
Chapter 3, the Azacitidine Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Azacitidine Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Azacitidine Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Azacitidine Drug.
Chapter 13, 14, and 15, to describe Azacitidine Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Azacitidine Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Azacitidine Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Vidaza®
1.2.3 Generic Vidaza®
1.3 Market Analysis by Application
1.3.1 Overview: Global Azacitidine Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Refractory anemia (RA)
1.3.3 Refractory anemia with excess blasts (RAEB)
1.3.4 Chronic myelomonocytic leukemia (CMMoL)
1.3.5 Others
1.4 Global Azacitidine Drug Market Size & Forecast
1.4.1 Global Azacitidine Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Azacitidine Drug Sales in Volume (2017-2028)
1.4.3 Global Azacitidine Drug Price (2017-2028)
1.5 Global Azacitidine Drug Production Capacity Analysis
1.5.1 Global Azacitidine Drug Total Production Capacity (2017-2028)
1.5.2 Global Azacitidine Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Azacitidine Drug Market Drivers
1.6.2 Azacitidine Drug Market Restraints
1.6.3 Azacitidine Drug Trends Analysis
2 Manufacturers Profiles
2.1 Celgene
2.1.1 Celgene Details
2.1.2 Celgene Major Business
2.1.3 Celgene Azacitidine Drug Product and Services
2.1.4 Celgene Azacitidine Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Azacitidine Drug Product and Services
2.2.4 Mylan Azacitidine Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Shilpa Medicare
2.3.1 Shilpa Medicare Details
2.3.2 Shilpa Medicare Major Business
2.3.3 Shilpa Medicare Azacitidine Drug Product and Services
2.3.4 Shilpa Medicare Azacitidine Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Accord Healthcare
2.4.1 Accord Healthcare Details
2.4.2 Accord Healthcare Major Business
2.4.3 Accord Healthcare Azacitidine Drug Product and Services
2.4.4 Accord Healthcare Azacitidine Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Natco Pharma
2.5.1 Natco Pharma Details
2.5.2 Natco Pharma Major Business
2.5.3 Natco Pharma Azacitidine Drug Product and Services
2.5.4 Natco Pharma Azacitidine Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dr. Reddy’s Laboratories
2.6.1 Dr. Reddy’s Laboratories Details
2.6.2 Dr. Reddy’s Laboratories Major Business
2.6.3 Dr. Reddy’s Laboratories Azacitidine Drug Product and Services
2.6.4 Dr. Reddy’s Laboratories Azacitidine Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Azacitidine Drug Breakdown Data by Manufacturer
3.1 Global Azacitidine Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Azacitidine Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Azacitidine Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Azacitidine Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Azacitidine Drug Manufacturer Market Share in 2021
3.5 Global Azacitidine Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Azacitidine Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Azacitidine Drug Market Size by Region
4.1.1 Global Azacitidine Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Azacitidine Drug Revenue by Region (2017-2028)
4.2 North America Azacitidine Drug Revenue (2017-2028)
4.3 Europe Azacitidine Drug Revenue (2017-2028)
4.4 Asia-Pacific Azacitidine Drug Revenue (2017-2028)
4.5 South America Azacitidine Drug Revenue (2017-2028)
4.6 Middle East and Africa Azacitidine Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Azacitidine Drug Sales in Volume by Type (2017-2028)
5.2 Global Azacitidine Drug Revenue by Type (2017-2028)
5.3 Global Azacitidine Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Azacitidine Drug Sales in Volume by Application (2017-2028)
6.2 Global Azacitidine Drug Revenue by Application (2017-2028)
6.3 Global Azacitidine Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Azacitidine Drug Sales by Type (2017-2028)
7.2 North America Azacitidine Drug Sales by Application (2017-2028)
7.3 North America Azacitidine Drug Market Size by Country
7.3.1 North America Azacitidine Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Azacitidine Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Azacitidine Drug Sales by Type (2017-2028)
8.2 Europe Azacitidine Drug Sales by Application (2017-2028)
8.3 Europe Azacitidine Drug Market Size by Country
8.3.1 Europe Azacitidine Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Azacitidine Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Azacitidine Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Azacitidine Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Azacitidine Drug Market Size by Region
9.3.1 Asia-Pacific Azacitidine Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Azacitidine Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Azacitidine Drug Sales by Type (2017-2028)
10.2 South America Azacitidine Drug Sales by Application (2017-2028)
10.3 South America Azacitidine Drug Market Size by Country
10.3.1 South America Azacitidine Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Azacitidine Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Azacitidine Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Azacitidine Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Azacitidine Drug Market Size by Country
11.3.1 Middle East & Africa Azacitidine Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Azacitidine Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Azacitidine Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Azacitidine Drug
12.3 Azacitidine Drug Production Process
12.4 Azacitidine Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Azacitidine Drug Typical Distributors
13.3 Azacitidine Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Azacitidine Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Azacitidine Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Celgene Basic Information, Manufacturing Base and Competitors
Table 4. Celgene Major Business
Table 5. Celgene Azacitidine Drug Product and Services
Table 6. Celgene Azacitidine Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Mylan Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Major Business
Table 9. Mylan Azacitidine Drug Product and Services
Table 10. Mylan Azacitidine Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Shilpa Medicare Basic Information, Manufacturing Base and Competitors
Table 12. Shilpa Medicare Major Business
Table 13. Shilpa Medicare Azacitidine Drug Product and Services
Table 14. Shilpa Medicare Azacitidine Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 16. Accord Healthcare Major Business
Table 17. Accord Healthcare Azacitidine Drug Product and Services
Table 18. Accord Healthcare Azacitidine Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Natco Pharma Major Business
Table 21. Natco Pharma Azacitidine Drug Product and Services
Table 22. Natco Pharma Azacitidine Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr. Reddy's Laboratories Major Business
Table 25. Dr. Reddy's Laboratories Azacitidine Drug Product and Services
Table 26. Dr. Reddy's Laboratories Azacitidine Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Azacitidine Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Azacitidine Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Azacitidine Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Azacitidine Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Azacitidine Drug Production Site of Key Manufacturer
Table 32. Azacitidine Drug New Entrant and Capacity Expansion Plans
Table 33. Azacitidine Drug Mergers & Acquisitions in the Past Five Years
Table 34. Global Azacitidine Drug Sales by Region (2017-2022) & (K Units)
Table 35. Global Azacitidine Drug Sales by Region (2023-2028) & (K Units)
Table 36. Global Azacitidine Drug Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Azacitidine Drug Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Azacitidine Drug Sales by Type (2017-2022) & (K Units)
Table 39. Global Azacitidine Drug Sales by Type (2023-2028) & (K Units)
Table 40. Global Azacitidine Drug Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Azacitidine Drug Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Azacitidine Drug Price by Type (2017-2022) & (USD/Unit)
Table 43. Global Azacitidine Drug Price by Type (2023-2028) & (USD/Unit)
Table 44. Global Azacitidine Drug Sales by Application (2017-2022) & (K Units)
Table 45. Global Azacitidine Drug Sales by Application (2023-2028) & (K Units)
Table 46. Global Azacitidine Drug Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Azacitidine Drug Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Azacitidine Drug Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Azacitidine Drug Price by Application (2023-2028) & (USD/Unit)
Table 50. North America Azacitidine Drug Sales by Country (2017-2022) & (K Units)
Table 51. North America Azacitidine Drug Sales by Country (2023-2028) & (K Units)
Table 52. North America Azacitidine Drug Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Azacitidine Drug Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Azacitidine Drug Sales by Type (2017-2022) & (K Units)
Table 55. North America Azacitidine Drug Sales by Type (2023-2028) & (K Units)
Table 56. North America Azacitidine Drug Sales by Application (2017-2022) & (K Units)
Table 57. North America Azacitidine Drug Sales by Application (2023-2028) & (K Units)
Table 58. Europe Azacitidine Drug Sales by Country (2017-2022) & (K Units)
Table 59. Europe Azacitidine Drug Sales by Country (2023-2028) & (K Units)
Table 60. Europe Azacitidine Drug Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Azacitidine Drug Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Azacitidine Drug Sales by Type (2017-2022) & (K Units)
Table 63. Europe Azacitidine Drug Sales by Type (2023-2028) & (K Units)
Table 64. Europe Azacitidine Drug Sales by Application (2017-2022) & (K Units)
Table 65. Europe Azacitidine Drug Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Azacitidine Drug Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Azacitidine Drug Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Azacitidine Drug Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Azacitidine Drug Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Azacitidine Drug Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Azacitidine Drug Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Azacitidine Drug Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Azacitidine Drug Sales by Application (2023-2028) & (K Units)
Table 74. South America Azacitidine Drug Sales by Country (2017-2022) & (K Units)
Table 75. South America Azacitidine Drug Sales by Country (2023-2028) & (K Units)
Table 76. South America Azacitidine Drug Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Azacitidine Drug Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Azacitidine Drug Sales by Type (2017-2022) & (K Units)
Table 79. South America Azacitidine Drug Sales by Type (2023-2028) & (K Units)
Table 80. South America Azacitidine Drug Sales by Application (2017-2022) & (K Units)
Table 81. South America Azacitidine Drug Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Azacitidine Drug Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Azacitidine Drug Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Azacitidine Drug Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Azacitidine Drug Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Azacitidine Drug Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Azacitidine Drug Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Azacitidine Drug Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Azacitidine Drug Sales by Application (2023-2028) & (K Units)
Table 90. Azacitidine Drug Raw Material
Table 91. Key Manufacturers of Azacitidine Drug Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Azacitidine Drug Typical Distributors
Table 95. Azacitidine Drug Typical Customers
List of Figures
Figure 1. Azacitidine Drug Picture
Figure 2. Global Azacitidine Drug Revenue Market Share by Type in 2021
Figure 3. Vidaza®
Figure 4. Generic Vidaza®
Figure 5. Global Azacitidine Drug Revenue Market Share by Application in 2021
Figure 6. Refractory anemia (RA)
Figure 7. Refractory anemia with excess blasts (RAEB)
Figure 8. Chronic myelomonocytic leukemia (CMMoL)
Figure 9. Others
Figure 10. Global Azacitidine Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Azacitidine Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Azacitidine Drug Sales (2017-2028) & (K Units)
Figure 13. Global Azacitidine Drug Price (2017-2028) & (USD/Unit)
Figure 14. Global Azacitidine Drug Production Capacity (2017-2028) & (K Units)
Figure 15. Global Azacitidine Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Azacitidine Drug Market Drivers
Figure 17. Azacitidine Drug Market Restraints
Figure 18. Azacitidine Drug Market Trends
Figure 19. Global Azacitidine Drug Sales Market Share by Manufacturer in 2021
Figure 20. Global Azacitidine Drug Revenue Market Share by Manufacturer in 2021
Figure 21. Azacitidine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Azacitidine Drug Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Azacitidine Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Azacitidine Drug Sales Market Share by Region (2017-2028)
Figure 25. Global Azacitidine Drug Revenue Market Share by Region (2017-2028)
Figure 26. North America Azacitidine Drug Revenue (2017-2028) & (USD Million)
Figure 27. Europe Azacitidine Drug Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Azacitidine Drug Revenue (2017-2028) & (USD Million)
Figure 29. South America Azacitidine Drug Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Azacitidine Drug Revenue (2017-2028) & (USD Million)
Figure 31. Global Azacitidine Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Azacitidine Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Azacitidine Drug Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Azacitidine Drug Sales Market Share by Application (2017-2028)
Figure 35. Global Azacitidine Drug Revenue Market Share by Application (2017-2028)
Figure 36. Global Azacitidine Drug Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Azacitidine Drug Sales Market Share by Type (2017-2028)
Figure 38. North America Azacitidine Drug Sales Market Share by Application (2017-2028)
Figure 39. North America Azacitidine Drug Sales Market Share by Country (2017-2028)
Figure 40. North America Azacitidine Drug Revenue Market Share by Country (2017-2028)
Figure 41. United States Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Azacitidine Drug Sales Market Share by Type (2017-2028)
Figure 45. Europe Azacitidine Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Azacitidine Drug Sales Market Share by Country (2017-2028)
Figure 47. Europe Azacitidine Drug Revenue Market Share by Country (2017-2028)
Figure 48. Germany Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Azacitidine Drug Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Azacitidine Drug Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Azacitidine Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Azacitidine Drug Revenue Market Share by Region (2017-2028)
Figure 57. China Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Azacitidine Drug Sales Market Share by Type (2017-2028)
Figure 64. South America Azacitidine Drug Sales Market Share by Application (2017-2028)
Figure 65. South America Azacitidine Drug Sales Market Share by Country (2017-2028)
Figure 66. South America Azacitidine Drug Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Azacitidine Drug Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Azacitidine Drug Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Azacitidine Drug Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Azacitidine Drug Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Azacitidine Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Azacitidine Drug in 2021
Figure 78. Manufacturing Process Analysis of Azacitidine Drug
Figure 79. Azacitidine Drug Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 注射用アザシチジンの世界市場2023年：先発医薬品、ジェネリック医薬品
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19166 )"世界のアザシチジン医薬品市場2022年：市場規模予測（～2028年）" (英文：Global Azacitidine Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。